No Picture
business

Biocon Announces U.S. Commercial Launch of Bosaya and Aukelso, Denosumab Biosimilars

New Delhi, India and BRIDGEWATER, N.J., United States: April 7: Biocon Limited, an innovation‑led global biopharmaceutical company, today announced the commercial launch of Bosaya™ (denosumab-kyqq) and Aukelso™ (denosumab-kyqq) in the United States. Bosaya™ (biosimilar to Prolia®) and Aukelso™ (biosimilar to Xgeva®) are now available by prescription nationwide through […]